Bharat Biotech to dispatch Covaxin in Q2 2021 Kumar Jeetendra | November 1, 2020 Bharat Biotech is planning to establish its own vaccine for COVID-19 in the second quarter next year when it will get the requisite approvals in the Indian regulatory authorities, a top company official said. It stated its immediate focus is to conduct the Phase 3 trials across websites in the nation. The company’s vaccine candidate …
Drug used to control pulse may improve malignant growth patients’ reaction to immunotherapy Kumar Jeetendra | November 1, 2020 The exact same biochemical triggers which spur a”flight or fight” reaction once we encounter threats may help tumor cells to thrive. A group of researchers from Roswell Park Comprehensive Cancer Center is looking at ways to interrupt that dynamic so that cancer therapies can be effective. Their latest work, published today in Clinical Cancer Research, …
CureVac’s COVID-19 antibody triggers invulnerable reaction in Phase I preliminary Kumar Jeetendra | November 2, 2020 CureVac’s experimental COVID-19 vaccine triggered an immune response in humans, it said on Monday, placing the German biotech firm on track to start mass testing this year since the race to end the pandemic heats up. “We are very encouraged by the interim Phase I data,” Chief Executive Officer Franz-Werner Haas said in a statement, …
Washing hands and Halloween candy can diminish COVID-19 introduction hazard Kumar Jeetendra | November 2, 2020 New research indicates that COVID-19 exposure risk from contaminated candy might be successfully mitigated either by washing hands and washing candy with a simple at-home technique. A group of researchers published this work today in mSystems, an open-access journal of the American Society for Microbiology. The researchers enrolled 10 recently diagnosed asymptomatic or mildly/moderately symptomatic …
Gilson Customized low-cost automated tube filling system – ideal for VTM Kumar Jeetendra | November 2, 2020 With the current pandemic, there is an exponential demand for diagnostic testing of patients for COVID-19, the disease caused by the SARS-CoV-2 virus. Viral transport media (VTM) is a critical component of COVID-19 test kits and is used for the collection, transport, and storage of clinical specimens. As companies and laboratories accelerate the manufacturing of …
A process system for the pharmaceutical company Boryung Pharmaceutical in Yesan led by Telstar Kumar Jeetendra | November 2, 2020 Terrassa (Barcelona) 2020, November 2nd. A turnkey vial filling line integrating a freeze dryer with automatic loading & unloading system under isolation technology designed for the production of drugs for cancer treatment has been completed for the new production facility of the South Korean pharmaceutical company Boryung Pharmaceutical in Yesan, South Chungcheong Province. The integrated …
South African firm Aspen Pharmacare and Johnson and Johnson strike immunization bargain Kumar Jeetendra | November 3, 2020 South African pharmaceutical company Aspen Pharmacare has announced a deal with U.S. firm Johnson & Johnson to manufacture its COVID-19 vaccine candidate, if it’s accepted in South Africa and internationally. In a statement issued on Monday, Aspen said that if ongoing trials bring global health authorities to endorse the J&J vaccine as safe and effective, …
Zydus Cadila finishes stage 2 preliminary, to submit information in November Kumar Jeetendra | November 3, 2020 Cadila Healthcare (Zydus Cadila) said it has completed enrolment and dosing of 1,000 volunteers in phase-2 clinical trials of its possible Covid-19 vaccine, ZyCoV-D, and plans to submit the data to the Drug Controller General of India (DCGI) this past month. “At present the immunogenicity evaluation is going on,” said Sharvil Patel, Managing Director of …
Blood vessel deformities start in vein cells Kumar Jeetendra | November 3, 2020 In the condition called cavernoma, lesions appear in a cluster of blood vessels in the brain, spinal cord or retina. Researchers from Uppsala University can now reveal, at molecular level, these changes originate in vein cells. This new understanding of the condition creates possibility of developing better treatments for patients. The study was published in …
CytoSMART Technologies announces the launch of its first fluorescence live-cell imager Lux3 FL Kumar Jeetendra | November 3, 2020 3 November 2020, Eindhoven, The Netherlands – Life Science Newswire – CytoSMART Technologies today announced its first fluorescence live-cell imager. The CytoSMART Lux3 FL is a small live-cell imaging microscope equipped with one brightfield and two fluorescent channels (green and red). The device enables researchers to unravel cellular processes in real-time, while the cells are …
Lincoln Pharmaceuticals Ltd reports 16.70% rise in the Standalone Net Profit at Rs. 35.19 crore in H1 FY21 Kumar Jeetendra | November 3, 2020 November 03, 2020: Lincoln Pharmaceuticals Limited, one of India’s leading healthcare companies has reported net profit of Rs. 35.19 crore for the H1 FY21 ended September 2020 as against net profit of Rs. 30.15 crore in the corresponding period last year, growth of 16.70%. Net revenue for the half year ended September 2020 reported at …
Himac Centrifuges – Now available from Eppendorf India Kumar Jeetendra | November 4, 2020 Chennai, November 2020 – In March Eppendorf AG and Koki Holdings Co., Ltd., have reached an agreement that Eppendorf acquires Koki’s centrifuge business, including the premium Himac brand. Since July 1st, 2020 Eppendorf Himac Technologies officially belongs to the Eppendorf Group. Since November 1st, 2020 Eppendorf India Pvt. Ltd. has been able to offer the …
